# Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer

> **NCT01452724** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 372 (actual)

## Conditions studied

- Duodenal Ulcer

## Interventions

- **DRUG:** TAK-438
- **DRUG:** Placebo
- **DRUG:** Lansoprazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01452724
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 372 (ACTUAL)
- **Last updated:** 2013-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01452724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01452724, "Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01452724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*